INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 217 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,716,000 | -0.1% | 185,140 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,718,000 | +3.0% | 185,140 | -1.7% | 0.01% | 0.0% |
| Q4 2020 | $1,668,000 | -24.7% | 188,436 | -1.3% | 0.01% | -33.3% |
| Q3 2020 | $2,215,000 | -41.3% | 190,938 | +36.4% | 0.01% | -43.8% |
| Q2 2020 | $3,773,000 | – | 139,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |